793 Combined administration of the dual A2aR/A2bR antagonist etrumadenant with a reduced chemotherapy regimen leads to enhanced tumor efficacy and survivalDaniel DiRenzo,Dana Piovesan,Sachie Marubayashi,Ferdie Soriano, Janine Kline,Matthew J Walters,Ruben Flores, Gonzalo BarajasJournal for ImmunoTherapy of Cancer（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
